MEDvidi operates an online mental health treatment platform that connects patients with licensed healthcare providers across 36 US states. Founded in 2019 and headquartered in San Jose, California, the company facilitates over 120,000 appointments annually through a network of more than 100 licensed providers including medical doctors, nurse practitioners, and physician assistants. The platform delivers medication management, prescription refills, and ongoing follow-up care for conditions including ADHD, anxiety, depression, insomnia, and OCD.
The company has integrated AI-powered clinical tools into its operations, including a prescribing assistant designed to support healthcare providers in delivering evidence-based care efficiently. These technical capabilities complement the core telehealth delivery model, which aims to reduce traditional barriers to mental healthcare access through affordability and convenience of remote treatment.
Treatment plans are personalized to individual patient needs, with the platform handling both initial psychiatric evaluation and long-term care coordination. The scale of operations - processing thousands of appointments monthly across a multi-state footprint - positions MEDvidi as a functional player in the telehealth mental health space serving patients who might otherwise face geographic, cost, or stigma-related obstacles to traditional in-person psychiatric care.